A University of Queensland spin-off company hopes to develop precision painkillers that are more accurate and less harmful to the liver. Professor Trent Munro, from the Australian Institute for Bioengineering and Nanotechnology (AIBN), is the scientific co-founder of Cassowary Pharmaceuticals, which is creating a new range of hyper-targeted pain medications. “This type of targeted therapy […]
Menu ≡ ╳ 
